| |
| |
|
| Insider
Information: |
Freund John Gordon |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
2,248,476 |
|
|
Indirect Shares
|
9,013,510 |
|
|
| Direct
Value |
$8,137,669 |
|
|
|
Indirect Value
|
$20,470,055 |
|
|
| Total
Shares |
11,261,986 |
|
|
| Total
Value |
$28,607,724 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 257.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2006-11-21 |
0 |
2009-04-17 |
2,000,936 |
Premium* |
|
|
Map Pharmaceuticals Inc |
MAPP |
Director, 10% Owner |
2011-02-14 |
1,984 |
2011-05-20 |
5,152 |
Premium* |
|
|
Mako Surgical Corp. |
MAKO |
Director |
|
0 |
2013-12-17 |
0 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
2011-02-16 |
0 |
2012-05-29 |
4,161,933 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2019-12-10 |
0 |
2019-12-10 |
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director, 10% Owner |
|
0 |
2014-02-20 |
1,208,920 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2019-11-08 |
2,175,882 |
2014-10-27 |
1,432,930 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2023-05-18 |
44,775 |
2023-05-18 |
43,413 |
Premium* |
|
|
Sutro Biopharma Inc |
STRO |
Director |
2018-10-01 |
0 |
2020-12-10 |
56,327 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
|
2023-08-09 |
25,835 |
2023-08-09 |
103,899 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SIBN |
Si-Bone, Inc. |
|
– • – |
2023-08-09 |
4 |
S |
$20.54 |
$616,197 |
I/I |
(30,000) |
103,899 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,866 |
25,835 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,792 |
44,775 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,324 |
20,969 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,035 |
34,983 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,848 |
12,645 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-05-28 |
4 |
S |
$30.06 |
$1,359,444 |
I/I |
(45,220) |
383,458 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-05-27 |
4 |
S |
$30.93 |
$815,523 |
I/I |
(26,367) |
428,678 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-05-26 |
4 |
S |
$31.85 |
$545,833 |
I/I |
(17,138) |
455,045 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-05-25 |
4 |
S |
$32.55 |
$55,197 |
I/I |
(1,696) |
472,183 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-05-24 |
4 |
S |
$32.54 |
$1,660,508 |
I/I |
(51,027) |
473,879 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,941 |
20,948 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-17 |
4 |
S |
$30.25 |
$20,243,688 |
I/I |
(666,200) |
524,906 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-16 |
4 |
S |
$30.33 |
$1,669,884 |
I/I |
(55,053) |
1,191,106 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-15 |
4 |
S |
$30.90 |
$2,499,586 |
I/I |
(80,887) |
1,246,159 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-12 |
4 |
S |
$31.39 |
$2,858,859 |
I/I |
(91,072) |
1,327,046 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-11 |
4 |
S |
$31.05 |
$1,984,741 |
I/I |
(63,928) |
1,418,118 |
0 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
I/I |
56,327 |
56,327 |
0 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-12-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(118,735) |
0 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2020-12-03 |
4 |
S |
$23.39 |
$1,120,197 |
I/I |
(47,886) |
1,482,046 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2020-12-02 |
4 |
S |
$23.28 |
$2,328,480 |
I/I |
(100,000) |
1,529,932 |
0 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-11-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(560,053) |
0 |
0 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-11-09 |
4 |
A |
$0.00 |
$0 |
I/I |
118,735 |
118,735 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • • |
2020-10-19 |
4 |
S |
$22.00 |
$4,181,166 |
I/I |
(190,053) |
2,129,932 |
0 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-09-18 |
4 |
S |
$12.00 |
$4,800,000 |
I/I |
(400,000) |
560,053 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
